The PSCI will exhibit as an Official Sustainability Partner of CPHI Milan from 6-8 October in Milan, Italy

The PSCI is delighted to be an Official Sustainability Partner for CPHI Milan, the biggest international pharma industry event, to raise awareness about building responsible supply chains.

We'll be exhibiting throughout the conference in Milan from 6-8 October, and attending the inaugural CPHI Sustainability Summit on Tuesday 6 October.

The PSCI stand H47 will be located in Hall 16, where we will be showcasing the impact that the PSCI has through the pharmaceutical supply chain.

Register for CPHI Milan
Registration is open on CPHI's website, accessible here. If you would like to register for CPHI's Sustainability Summit, please click here.

Meet with us on-site
Are you or your colleagues attending the fair? Contact the Secretariat to arrange a meeting, we would be delighted to meet with you.

Showcase your PSCI engagement on your stand
If you are a PSCI Supplier Partner, we encourage you to display the PSCI logo or Supplier Partner badge on your own exhibition stand and marketing materials. This not only demonstrates your commitment to responsible practices, but also shows your relationship to the industry's leading association for delivering responsible value chains. Contact the Secretariat for the assets and share them with your Marketing team.

Important notice regarding audit firm application

The PSCI will temporarily hold off on reviewing new audit firm applications while we finalize key updates to the audit firm agreement and fee structure. This pause allows us to ensure that all new and existing firms will be onboarded under a renewed, consistent framework once the updated agreement is in place.

Timeline

We expect the fee structure and renewed agreement to be finalized in Q4 2026, with the terms taking effect for all firms in January 2027. We will resume application reviews as soon as the new agreement is finalized.

SEOUL, Republic of Korea — The PSCI is excited to be part of CPHI Korea 2026, taking place at the COEX Convention & Exhibition Center in Seoul from August 25 to 27.

This year marks the largest edition of CPHI Korea to date, bringing together over 420 exhibiting companies and an estimated 12,000+ industry professionals from around the world. Our collaboration aims to bring a focus on sustainable supply chain practices to the region's rapid growth as a global hub for pharmaceutical and biopharmaceutical innovation.

Reflecting strong industry momentum, the conference program has expanded to six tracks covering the sector's latest technical and regulatory updates. Members of the PSCI will be contributing content during the event, sharing insights about our collective approach to responsible supply chain management.

Companies considering participation are encouraged to apply early.

• Pre-registration is available at the following link
• For exhibition and booth inquiries, please contact: cphi-kr@informa.com

NHS England has published new guidance setting out what suppliers need to do from April 2027 as part of the NHS Net Zero Supplier Roadmap – their shared commitment to reaching net zero by 2045.

From 1st April 2027, the NHS will implement new proportionate requirements for suppliers to publicly report targets, emissions and publish the Carbon Reduction Plan for all of their relevant global scope 1, 2 and 3 emissions.

Following extensive engagement with stakeholders, NHS England has now published the guidance, 2027 NHS Carbon reduction plan requirements for the procurement of NHS goods, services and works along with the Market sounding findings: net zero supplier requirements from April 2027. Together, these documents set out the approach to Scope 3 target setting and reporting, and outline how stakeholder feedback has informed the final policy approach.

The development of this guidance has been a collaborative effort and builds on the feedback received through engagement activities. It supports delivery of the NHS’s net zero commitment, as set out in Delivering a Net Zero National Health Service, whilst providing clarity for procurement teams and suppliers on what is required and how to prepare for the requirements that will go live from April 2027.

Suppliers can utilize available support to meet the requirements through:

• Upcoming NHS England Webinars on the requirements, Tuesday 16th June at 11am BST and Tuesday 23rd June at 2pm BST, as well as future webinars and additional on demand support videos here.
• NHS England’s Sustainable Supplier Accelerator Programme – providing support on areas like carbon accounting and target setting.
• The UK Business Climate Hub – hosting a range of free to use resources, tools and calculators.
• Utilizing the NHS Evergreen Sustainable Supplier Assessment to check the content of their CRP against the requirements of the policy using the maturity levels.

THE PSCI PRESENTS ITS ANNUAL PUBLIC AUDIT FINDINGS REPORT, PROVIDING CONTINUED INSIGHTS AND REVIEW OF SUPPLIER PRACTICES, REFLECTING THE COMMITMENT OF THE PSCI AND ITS MEMBERS TO A RESPONSIBLE, RESILIENT PHARMACEUTICAL AND HEALTHCARE SUPPLY CHAIN.

The PSCI’s audit findings are analyzed to identify trends, highlight improvements, and share recommendations. The analysis provides deep insight into supplier practices within the pharmaceutical and healthcare industry. In 2025, pharmaceutical and healthcare companies carried out thousands of supplier site audits, each typically representing two to four days of dedicated on-site work from both auditors and suppliers. Members of the PSCI collaborate by sharing these audits, with their suppliers’ permission, promoting greater transparency and creating efficiencies that benefit all parties involved.

In 2025, Members and suppliers uploaded a record number of over 240 audits to the PSCI platform, reflecting a significant collective effort. These audits generated more than 2,500 findings identified by auditors across the five PSCI Principles: Governance & Management Systems, Ethics, Human Rights, Environment, and Health & Safety. The analysis presented in this report offers a snapshot of suppliers’ real-world practices, highlighting recurring challenges and identifying areas where joint action can deliver the greatest impact.

The report is structured in three parts:

1. A deep dive exploring the most common findings within each Principle, supported by qualitative examples from auditor observations.
2. A regional analysis looking at patterns in China, India, the United States, Western Europe, and other regions.
3. An insights section further interpreting findings from the perspectives of supplier categories, audit topic coverage, and onsite vs remote audits.

The report identifies several key trends across the PSCI Principles:

• Health & Safety remains the largest source of findings by volume, reflecting consistent auditor focus on this business-critical and potentially life-threatening topic.
• Environment findings nearly doubled, from 221 in 2024 to 435 in 2025, with Waste & Emissions as the largest sub-topic.
• Governance & Management Systems and Human Rights findings decreased, showing a slight shift of audit focus towards topics like hazardous waste handling and associated vendor qualification, as well as API discharge risk assessment.
• Relatively small number of Human Rights findings, especially for topics related to Wage, Benefits, & Working Hours, were recorded at a high severity level, which flags basic labor practices as an important management theme for suppliers.

Birgit Skuballa, Co-lead of the PSCI Audit Committee and Director of ESG Governance at Bayer reflected on this year’s findings.

“What stands out to me in this report is not only the scale of the effort behind these audits, but also the opportunity they create. Every finding tells us something important about where suppliers are making progress and where more support is needed. By sharing insights, identifying common challenges, and providing support through conferences, webinars, training materials, and practical tools, we can move beyond individual findings and drive broader, more consistent improvement across global pharmaceutical supply chains.”

The Audit Findings Analysis report demonstrates the PSCI Members’ shared goal to translate audit evidence into actionable insights. These insights prioritize the PSCI’s provision of supplier training topics, practical guidance, and collaboration with regional partners, ultimately supporting safer work, stronger rights, reduced environmental impact, and responsible business conduct across global supply chains.

For more details, access the full report in the resource attached.